REJYONEL ANESTEZİK PROSEDÜRLER: İntravenöz Rejyonel Anestezi

Authors

Metin Alkan
Ayşe Börklüce

Synopsis

Intravenous regional anesthesia (IVRA), also known as Bier block, is a simple and highly effective regional anesthesia technique used for short surgical procedures lasting 20 to 60 minutes in the distal upper or lower extremities. The main mechanism of action involves the retrograde diffusion of the local anesthetic into small peripheral nerves, conduction blockade of larger proximal nerves, direct nerve compression by the pneumatic tourniquet, and tourniquet-induced tissue ischemia. Due to its extensive safety record and distinct advantages, 0.5% lidocaine is the most widely used local anesthetic. Although various additives can be used to improve block quality, extend postoperative analgesia, and enhance tourniquet tolerance, 20 mg of ketorolac is considered the ideal adjuvant in terms of safety, efficacy, and cost-effectiveness. IVRA is strictly contraindicated in ischemic vascular disease and sickle cell anemia. The major complication risk of the procedure is local anesthetic systemic toxicity (LAST). To minimize this risk, an appropriate leak-free pneumatic tourniquet must be used, the drug should be injected slowly into a distal vein over more than 90 seconds, the tourniquet must not be deflated during the first 20 minutes following injection, and deflation should be performed in a staged manner. Additionally, resuscitation equipment and a contralateral IV line must be readily available during the procedure.

References

RosenbergPH. Intravenousregional anesthesia: nerve block by multiple mechanisms. RegAnesth1993;18:1–5.

Estebe JP, Gentilli ME, Langlois G, et al. Lidocaine priming reduces tourniquet pain during intravenous regional anesthesia: a preliminary study. Reg Anesth Pain Med 2003;28:120–123.

Atanassoff PG, Ocampo CA, Bande MC, et al. Ropivacaine 0.2% and lidocaine 0.5% for intravenous regional anesthesia in outpatient surgery. Anesthesiology 2001;95:627–631.

Neal JM, Bernards CM, Butterworth JF, et al. ASRA practice advisory on local anesthetic systemic toxicity. Reg Anesth Pain Med 2010;35:152–161.

Marsch SC, Sluga M, Studer W, et al. 0.5% versus 1.0% 2-chloroprocaine for intravenous regional anesthesia: a prospective, randomized, double-blind trial. Anesth Analg 2004;98:1789–1793.

Choyce A, Peng P. A systematic review of adjuvants for intravenous regional anesthesia for surgical pro-cedures. Can J Anaesth 2002;49:32–45.

Reuben SS, Steinberg RB, Klatt J, et al. Intravenous regional anesthesia using lidocaine and clonidine. Anesthesiology 1999;91:654–658.

Memis D, Turan A, Karamanlioglu B, et al. Adding dexmedetomidine to lidocaine for intravenous regional anesthesia. Anesth Analg 2004;98:835–840.

Grice SC, Morell RC, Balestrieri FJ, et al. Intravenous regional anesthesia: evaluation and prevention of leakage under the tourniquet. Anesthesiology 1986;65:316–320.

Coleman MM, Peng PW, Regan JM, et al. Quantitative comparison of leakage under the tourniquet in forearm versus conventional intravenous regional anesthesia. Anesth Analg 1999;89:1482–1486.

Perlas A, Peng PW, Plaza MB, et al. Forearm rescue cuff improves tourniquet tolerance during intravenous regional anesthesia. Reg Anesth Pain Med 2003;28:98–102.

Tucker GT, Boas RA. Pharmacokinetic aspects of intravenous regional anesthesia. Anesthesiology 1971;34:538–549.

Sukhani R, Garcia CJ, Munhal RJ, et al. Lidocaine disposition following intravenous regional anesthesia with different tourniquet deflation techniques. Anesth Analg 1965;68:633.

Guay J. Adverse events associated with intravenous regional anesthesia (Bier block): a systematic review of complications. J Clin Anesth 2009;21:585–594.

Published

May 18, 2021

License

License